Abstract
Pre-transfusion testing involves blood grouping (ABO and Rh) and major cross match (testing the recipient's serum/plasma against the donor's red blood cells) at 37 °C to detect IgG antibodies. In the western countries, type and screen policy is routinely followed. This study was conducted to assess implementation of type and screen policy in standalone blood banks in India and to assess compromise on blood safety, if any? The study was carried out at the Standalone Blood Bank of North India during the period January 2012 to April 2012. Type and screen study was carried out in parallel to routine cross match using Column Agglutination Technology. Total 354 patients were included in the study. 4 samples were positive on antibody screening. Cross match was incompatible in 1 case. No case was found with antibody screen negative but AHG cross match incompatible. This study concluded good safety level in high risk category patients. Type and screen policy can be implemented in Indian settings with no compromise on blood safety provided sufficient technical and infrastructural support is available at the centre.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
